临床实践中的影像引导与摆位精度:摆位误差和成像剂量对头颈部肿瘤放疗实际剂量分布的影响
本研究基于40例头颈部肿瘤患者的治疗计划,模拟不同影像引导场景评估成像剂量,并利用实际摆位台位移评估摆位误差对剂量分布的影响。结果显示,每日MV三维成像验证带来不可忽视的高剂量,而kV成像即使每日三维成像对计划质量影响也有限;摆位误差导致危及器官保护和正常组织并发症概率变差,靶区覆盖也受损。定期摆位验证对精准放疗至关重要。
要点
- 每日MV三维影像验证摆位产生不可忽视的高剂量。
- kV成像即使每日三维成像对计划质量影响也有限,主要涉及危及器官保护。
- 摆位误差导致该组患者危及器官保护和NTCP变差,靶区覆盖也受损。
核心结论
- 定期摆位验证对精准放疗至关重要。
- 就额外剂量而言,kV模态在任何频率和技术下均无临界风险。
- 该组患者因摆位误差导致的剂量涂抹主要造成危及器官保护下降,靶区覆盖也因摆位不精确而受损,尤其对个别患者。
- 综合考虑两种效应,广泛IGRT的相关性明确存在,即使以额外成像剂量和时间消耗为代价。
研究设计与样本
- 本研究基于40例头颈部肿瘤患者的治疗计划。
- 模拟不同能量、技术和频率的影像引导场景并叠加至原计划以评估成像剂量。
- 利用实际应用的摆位台位移评估摆位误差影响,将等中心相应移回以模拟未进行摆位校正。
- 对单次分次按三种场景汇总移位的计划:仅汇总移位计划、对进行摆位验证的分次考虑原计划、以及在后一场景中叠加额外成像剂量。
主要发现
- 每日使用MV三维成像验证患者摆位导致不可忽视的高剂量。
- kV成像对计划质量仅有边际影响,主要与危及器官保护相关,即使每日三维成像。
- 对该组患者,危及器官保护和NTCP因潜在摆位误差而变差。
- 靶区覆盖也因摆位不精确而受损,尤其对个别患者。
临床怎么用
- 定期摆位验证对精准放疗至关重要。
- 就额外剂量而言,kV模态在任何频率和技术下均无临界风险。
- 综合考虑两种效应,广泛IGRT的相关性明确存在,即使以额外成像剂量和时间消耗为代价。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Modern radiotherapy offers the possibility of highly accurate tumor treatment. To benefit from this precision at its best, regular positioning verification is necessary. By the use of image-guided radiotherapy and the application of safety margins the influence of positioning inaccuracies can be counteracted. In this study the effect of additional imaging dose by set-up verification is compared with the effect of dose smearing by positioning inaccuracies for a collective of head-and-neck cancer patients. METHODS: This study is based on treatment plans of 40 head-and-neck cancer patients. To evaluate the imaging dose several image guidance scenarios with different energies, techniques and frequencies were simulated and added to the original plan. The influence of the positioning inaccuracies was assessed by the use of real applied table shifts for positioning. The isocenters were shifted back appropriately to these values to simulate that no positioning correction had been performed. For the single fractions the shifted plans were summed considering three different scenarios: The summation of only shifted plans, the consideration of the original plan for the fractions with set-up verification, and the addition of the extra imaging dose to the latter. For both effects (additional imaging dose and dose smearing), plans were analyzed and compared considering target coverage, sparing of organs at risk (OAR) and normal tissue complication probability (NTCP). RESULTS: Daily verification of the patient positioning using 3D imaging with MV energies result in non-negligible high doses. kV imaging has only marginal influence on plan quality, primarily related to sparing of organs at risk, even with daily 3D imaging. For this collective, sparing of organs at risk and NTCP are worse due to potential positioning errors. CONCLUSION: Regular set-up verification is essential for precise radiation treatment. Relating to the additional dose, the use of kV modalities is uncritical for any frequency and technique. Dose smearing due to positioning errors for this collective mainly resulted in a decrease of OAR sparing. Target coverage also suffered from the positioning inaccuracies, especially for individual patients. Taking into account both examined effects the relevance of an extensive IGRT is clearly present, even at the expense of additional imaging dose and time expenditure.
引用
- Bell K, Licht N, Rübe C, et al. Image guidance and positioning accuracy in clinical practice: influence of positioning errors and imaging dose on the real dose distribution for head and neck cancer treatment. Radiat Oncol. 2018. PMID: 30285806. doi:10.1186/s13014-018-1141-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。